【レポートの概要（一部）】
1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study
3 Executive Summary (Page No. – 29)
3.1 Introduction
3.2 Conclusion
4 Premium Insights (Page No. – 33)
4.1 Perfusion Systems: Market Overview
4.2 Geographic Analysis: Perfusion Systems Market, By Type (2016)
4.3 Cell Perfusion Systems Market, By Type, 2016 vs 2021
4.4 Geographic Snapshot of the Market
5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Cardiovascular and Respiratory Diseases
5.2.1.2 Rising Number of Organ Transplantations
5.2.1.2.1 Growth in Aging Population, Increasing Incidence of Multiple Organ Failures
5.2.1.2.2 Government and NGO Initiatives to Encourage Organ Donation
5.2.1.3 Increasing Investments in Cell-Based Research
5.2.1.4 Increase in Biologic Manufacturing
5.2.2 Restraints
5.2.2.1 High Cost of Organ Transplantation
5.2.2.2 Ethical Concerns and High Cost of Cell-Based Research
5.2.3 Opportunities
5.2.3.1 Increasing Pharmaceutical Research in Emerging Markets
5.2.3.2 Rising Preference for Continuous Manufacturing
5.2.4 Challenge
5.2.4.1 Organ Supply-Demand Gap
6 Cardiopulmonary Perfusion Systems Market, By Component (Page No. – 43)
6.1 Introduction
6.2 Oxygenators
6.3 Heart-Lung Machines
6.4 Perfusion Pumps
6.5 Cannulas
6.6 Monitoring Systems
6.7 Other Components
6.7.1 Arterial Filters
6.7.2 Reservoirs
6.7.3 Data Management Systems
6.7.4 Cardioplegia Delivery Systems
6.7.5 Heat Exchangers
6.7.6 Accessories
7 Cell Perfusion Systems Market, By Type (Page No. – 49)
7.1 Introduction
7.2 Bioreactor Perfusion Systems
7.3 Microfluidic Perfusion Systems
7.4 Gravity Or Pressure-Driven Perfusion Systems
7.5 Small-Mammal Organ Perfusion Systems
8 EX Vivo Organ Perfusion Market, By Technique (Page No. – 53)
8.1 Introduction
8.2 Hypothermic Machine Perfusion
8.3 Normothermic Machine Perfusion
9 Global Perfusion Systems Market, By Region (Page No. – 57)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Rise in Cardiovascular Disease Prevalence
9.2.1.2 Technological Advancements in Organ Preservation
9.2.1.3 Increasing Organ Transplants
9.2.1.4 Introduction of the 21st Century Cures Act
9.2.1.5 Favorable Scenario for Cell Research, Growing Research Funding
9.2.1.6 Growth of the Pharmaceutical and Biotechnology Sector
9.2.2 Canada
9.2.2.1 Increasing Incidences of Heart Diseases
9.2.2.2 Favorable Reimbursement Scenario for Living Donors Within Some Provinces
9.2.2.3 Increasing Investment in Regenerative Medicine Research Projects
9.3 Europe
9.3.1 Rapidly Aging Population, High Prevalence of Cardiovascular Diseases in Europe
9.3.2 Europe-5
9.3.2.1 Changes in Organ Donation Laws in Wales
9.3.2.2 Strong Academic and Research Base in Germany
9.3.2.3 Funding for Research in the U.K.
9.3.2.4 Increasing Cancer Research in France
9.3.2.5 Italy: Growing Biotech Industry to Aid Market Growth
9.3.3 RoE
9.3.3.1 Strong Presence of Pharmaceutical and Biotechnology Companies
9.3.3.2 Increasing Research in Denmark and Sweden
9.4 Asia-Pacific
9.4.1 Increasing Aging Population, Rise in Cardiovascular Surgery
9.4.2 Japan
9.4.2.1 Rising Organ Donations and Transplants
9.4.2.2 Rise in Vaccine Production in Japan
9.4.2.3 Regenerative Medicine and Biomedical & Medical Research in Japan
9.4.3 China
9.4.3.1 Regulatory Framework for Voluntary Organ Donations
9.4.3.2 Increasing Government Interest in Biomedical and Biotechnology Industries
9.4.3.3 Growth of the Pharmaceutical and Biotechnology R&D Industry and Cros Sector
9.4.4 India
9.4.4.1 Religious Beliefs and Lack of Healthcare Infrastructure in India
9.4.4.2 Growing Pharmaceutical and Biotechnology Industry, Government Initiatives
9.4.5 Rest of Asia-Pacific
9.4.5.1 Taiwan: Increasing Government Support for Academic and Commercial R&D
9.4.5.2 Establishment of R&D Centers in Singapore
9.4.5.3 Korea-U.S. Free Trade Agreement (Korus)
9.5 Rest of the World
9.5.1 Campaigns to Encourage Organ Donation in Brazil
9.5.2 Flourishing Biotechnology and Pharmaceutical Markets in Brazil
9.5.3 Significant Developments in the Pharmaceutical Market in Africa
9.5.4 Favorable Regulatory Environment in Saudi Arabia, Iran, and Israel
10 Competitive Landscape (Page No. – 97)
10.1 Introduction
10.1.1 Vanguards
10.1.2 Innovator
10.1.3 Dynamic
10.1.4 Emerging
10.2 Competitive Benchmarking
10.2.1 Product Offerings
10.2.2 Business Strategy
*Top 13 Companies Analyzed for This Studies are – Getinge AB (Sweden), Medtronic PLC (Ireland), Terumo Corporation (Japan), Livanova PLC (U.K.), Xenios AG (Germany), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Nipro Corporation (Japan), Harvard Bioscience, Inc. (U.S.), ALA Scientific Instruments, Inc. (U.S.), Lifeline Scientific, Inc. (U.S.), and Xvivo Perfusion AB (Sweden).
11 Company Profile (Page No. – 101)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Getinge AB
11.2 Medtronic PLC
11.3 Livanova PLC
11.4 Terumo Corporation
11.5 Nipro Corporation
11.6 Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)
11.7 Repligen Corporation
11.8 Spectrum Laboratories, Inc.
11.9 Merck KGaA
11.10 Harvard Bioscience, Inc.
11.11 ALA Scientific Instruments, Inc.
11.12 Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
11.13 Xvivo Perfusion AB
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 144)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.3.1 Features and Benefits of RT
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details
List of Tables (74 Tables)
Table 1 Biomanufacturing Projects Announced in 2015 and 2016
Table 2 Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 3 Oxygenators Market Size, By Region, 2014-2021 (USD Million)
Table 4 Heart-Lung Machines Market Size, By Region, 2014-2021 (USD Million)
Table 5 Perfusion Pumps Market Size, By Region, 2014-2021 (USD Million)
Table 6 Cannulas Market Size, By Region, 2014-2021 (USD Million)
Table 7 Monitoring Systems Market Size, By Region, 2014-2021 (USD Million)
Table 8 Other Components Market Size, By Region, 2014-2021 (USD Million)
Table 9 Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 10 Bioreactor Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 11 Microfluidic Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 12 Gravity Or Pressure-Driven Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 13 Small-Mammal Organ Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 14 EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 15 Advantages and Disadvantages of the HMP Technique
Table 16 Hypothermic Machine Perfusion Market Size, By Region, 2014-2021 (USD Million)
Table 17 Normothermic Machine Perfusion Market Size, By Region, 2014-2021 (USD Million)
Table 18 Global Market Size, By Region, 2014-2021 (USD Million)
Table 19 Global Market Size, By Type, 2014-2021 (USD Million)
Table 20 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 21 North America: Market Size, By Type, 2014-2021 (USD Million)
Table 22 North America: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 23 North America: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 24 North America: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 25 Number of Organ Transplants in the U.S. (2014-2016)
Table 26 U.S.: Market Size, By Type, 2014-2021 (USD Million)
Table 27 U.S.: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 28 U.S.: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 29 U.S.: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 30 Canada: Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 31 Canada: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 32 Canada: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 33 Canada: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 34 Europe: Market Size, By Region, 2014-2021 (USD Million)
Table 35 Europe: Market Size, By Type, 2014-2021 (USD Million)
Table 36 Europe: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 37 Europe: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 38 Europe: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 39 Europe-5: Market Size, By Type, 2014-2021 (USD Million)
Table 40 Europe-5: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 41 Europe-5: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 42 Europe-5: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 43 Indicative List: Companies Headquartered in RoE Countries
Table 44 RoE: Market Size, By Type, 2014-2021 (USD Million)
Table 45 RoE: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 46 RoE: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 47 RoE: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 48 Asia-Pacific: Market Size, By Country, 2014-2021 (USD Million)
Table 49 Asia-Pacific: Market Size, By Type, 2014-2021 (USD Million)
Table 50 Asia-Pacific: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 51 Asia-Pacific: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 52 Asia-Pacific: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 53 Number of Organ Donations and Transplants in Japan (2013-2016)
Table 54 Japan: Market Size, By Type, 2014-2021 (USD Million)
Table 55 Japan: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 56 Japan: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 57 Japan: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 58 China: Market Size, By Type, 2014-2021 (USD Million)
Table 59 China: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 60 China: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 61 China: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 62 India: Market Size, By Type, 2014-2021 (USD Million)
Table 63 India: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 64 India: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 65 India: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 66 RoAPAC: Market Size, By Type, 2014-2021 (USD Million)
Table 67 RoAPAC: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 68 RoAPAC: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 69 RoAPAC: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 70 Number of Organ Donations (2008 vs 2015)
Table 71 RoW: Market Size, By Type, 2014-2021 (USD Million)
Table 72 RoW: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 73 RoW: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 74 RoW: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
List of Figures (61 Figures)
Figure 1 Perfusion Systems Market Segmentation
Figure 2 Perfusion Systems Market: Research Methodology Steps
Figure 3 Sampling Frame: Primary Research
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Research Design
Figure 8 Data Triangulation Methodology
Figure 9 Perfusion Systems Market, By Type: Cardiopulmonary Perfusion Systems Segment Accounted for the Largest Market Share in 2016
Figure 10 Cardiopulmonary Perfusion Systems Market Size, By Component, 2016 vs 2021
Figure 11 EX Vivo Organ Perfusion Market Size (USD Million), By Technique, 2016 vs 2021
Figure 12 Cell Perfusion Systems Market Size, By Type, 2016 vs 2021
Figure 13 Geographic Snapshot of the Market
Figure 14 North America Accounted for the Largest Share of the Perfusion Systems Market in 2016
Figure 15 Cardiopulmonary Perfusion Segment Dominated the Perfusion Systems Market in 2016
Figure 16 Bioreactor Perfusion Systems Will Continue to Dominate the Cell Perfusion Systems Market in 2021
Figure 17 North America to Register the Highest CAGR During the Forecast Period
Figure 18 Global Market Share, By Region (2016–2021)
Figure 19 North America: Market Snapshot
Figure 20 NIH Spending on Stem Cell Research, 2013-2016 (USD Billion)
Figure 21 Number of New Biotechnology and Pharmaceutical Companies, 2014-2016
Figure 22 Europe: Market Snapshot
Figure 23 APAC: Market Snapshot
Figure 24 RoW: Market Snapshot
Figure 25 Dive Chart
Figure 26 Getinge AB: Company Snapshot (2016)
Figure 27 Getinge AB: Product Offering Scorecard
Figure 28 Getinge AB: Business Strategy Scorecard
Figure 29 Medtronic PLC: Company Snapshot (2016)
Figure 30 Medtronic PLC: Product Offering Scorecard
Figure 31 Medtronic PLC: Business Strategy Scorecard
Figure 32 Livanova PLC: Company Snapshot (2015)
Figure 33 Livanova PLC: Product Offering Scorecard
Figure 34 Livanova PLC: Business Strategy Scorecard
Figure 35 Terumo Corporation: Company Snapshot (2015)
Figure 36 Terumo Corporation: Product Offering Scorecard
Figure 37 Terumo Corporation: Business Strategy Scorecard
Figure 38 Nipro Corporation: Company Snapshot (2015)
Figure 39 Nipro Corporation: Product Offering Scorecard
Figure 40 Nipro Corporation: Business Strategy Scorecard
Figure 41 Xenios AG: Product Offering Scorecard
Figure 42 Xenios AG: Business Strategy Scorecard
Figure 43 Repligen Corporation: Company Snapshot (2015)
Figure 44 Repligen Corporation: Product Offering Scorecard
Figure 45 Repligen Corporation: Business Strategy Scorecard
Figure 46 Spectrum Laboratories, Inc.: Product Offering Scorecard
Figure 47 Spectrum Laboratories, Inc.: Business Strategy Scorecard
Figure 48 Merck KGaA: Company Snapshot (2015)
Figure 49 Merck KGaA: Product Offering Scorecard
Figure 50 Merck KGaA: Business Strategy Scorecard
Figure 51 Harvard Bioscience, Inc.: Company Snapshot (2015)
Figure 52 Harvard Bioscience, Inc.: Product Offering Scorecard
Figure 53 Harvard Bioscience, Inc.: Business Strategy Scorecard
Figure 54 ALA Scientific Instruments, Inc.: Product Offering Scorecard
Figure 55 ALA Scientific Instruments, Inc.: Business Strategy Scorecard
Figure 56 Lifeline Scientific, Inc.: Company Snapshot (2015)
Figure 57 Lifeline Scientific, Inc.: Product Offering Scorecard
Figure 58 Lifeline Scientific, Inc.: Business Strategy Scorecard
Figure 59 Xvivo Perfusion AB: Company Snapshot (2015)
Figure 60 Xvivo Perfusion AB: Product Offering Scorecard
Figure 61 Xvivo Perfusion AB: Business Strategy Scorecard
【レポート販売概要】
■ タイトル：灌流装置の世界市場予測（～2021年）■ 英文：Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021
■ 発行日：2017年4月24日
■ 調査会社：MarketsandMarkets
■ 商品コード：MAM-MD5190
■ 調査対象地域：グローバル
- 出版の世界市場：新聞発行、書籍発行、雑誌発行About Publishing Publishing refers to the process of communicating a set of information to the public through print, recording, TV, radio, or the internet. It involves writing, editing, and distributing content through print and digital medium. Publishing includes several industries such as education, banking and finance, music, government, and healthcare. In this report, we have considered only p …
- Orthostatic Hypotension：グローバル臨床試験レビューH1, 2014Orthostatic Hypotension Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Orthostatic Hypotension Global Clinical Trials Review, H1, 2014" provides data on the Orthostatic Hypotension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Orthostatic Hypotension. It includes an overview of the trial numbers …
- 世界の位置情報サービス(LBS)市場動向（2012-2016）TechNavio's analysts forecast the Global Location-based Service (LBS) market to grow at a CAGR of 35.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of GPS-enabled devices. The Global LBS market has also been witnessing the increasing adoption of LBS across various industries. However, the increasing concern associated with …
- ギリシャヨーグルトの世界市場2016-2020About the Greek Yogurt Market Greek yogurt is a type of yogurt prepared by traditional techniques practiced in Greece, which is the place of origin of this product. The preparation of Greek (strained or drained) yogurt is similar to that of regular yogurt but with an additional step in which the liquid whey (containing water, lactose, some protein, and minerals) is allowed to drain out of the yogu …
- 自動車用インホイールモーターの世界市場2019-2023About this market Automotive technologies are increasingly inclining toward driver comfort, safety, and emissions control. These technological advancements will lead to the development of autonomous driving systems in the future. The development of autonomous technologies is viewed as an important milestone for every automaker. Hence, manufacturers of automotive components are striving to develop …
- FRP（ガラス繊維強化プラスチック）筋の世界市場予測（～2021）The global market size of FRP rebars, in terms of value, is projected to reach USD 91.00 Million by 2021, at a CAGR of 11.4% between 2016 and 2021. The increasing number of patents filed for FRP rebars products & applications by global players, growing projects, continuous agreements, and expansion activities undertaken by companies are key factors for the growth of the global market for FRP rebar …
- フットウェアの世界市場2019-2023Global Footwear Market: About this market The footwear offered in the market is made up of various raw materials such as leather, natural rubber, synthetic rubber, ethylene-vinyl acetate (EVA), polyvinyl chloride (PVC), polyurethane (PU), and textiles. Technavio’s footwear market analysis considers sales from both athletic footwear and non-athletic footwear. Our analysis also considers the sales o …
- 医療用シリコーンの世界市場：シリコーンゲル、ソフトスキン接着剤、感圧接着剤、塗料、液状シリコーンThe market size of medical grade silicone, in terms of value, is projected to reach USD 7.23 Billion by 2021, at a CAGR of 9.4%, between 2016 and 2021. High-growth application areas such as prosthetics & orthopedic and rapid growth of the global healthcare industry are the key factors driving the growth of the medical grade silicone market. Medical grade silicones are extremely adaptable to change …
- Pakistan Refinery Limited：石油・ガスバリューチェーン分析レポート2013Pakistan Refinery Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Pakistan Refinery Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Pakistan Refinery Limited”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. …
- ケーブルトレイの世界市場2017-2021About Cable TrayA cable tray is a subset of cable management systems. Cable trays are used to provide mechanical support and protection to electrical cables or wires that are used for power distribution and data communication within a building. They can support various types of wires — high-voltage power lines, power distribution cables, sensitive control wiring, telecommunication wiring, and opti …
- ケーブル試験および認証の世界市場予測（～2023年）“Increasing use of cables due to the rise in electricity generation in the OECD and non-OECD countries to drive the growth of the cable testing and certification market”The cable testing and certification market is estimated at USD 11.3 billion in 2018 and is projected to reach USD 14.7 billion by 2023, at a CAGR of 5.4% between 2018 and 2023. The cable testing and certification market is driven b …
- 世界のソフトスイッチ産業分析：Analyzing the Global Softswitch IndustryA softswitch, an abbreviated form of ‘software switch’, is a generic term for any open application program interface (API) software that is used to bridge a traditional Public Switched Telephone Network (PSTN) and Voice Over Internet Protocol (VoIP), by linking PSTN to IP (Internet Protocol) networks and managing traffic that contains a mixture of voice, fax, data and video. A softswitch separates …
- メキシコの麻酔装置・呼吸装置市場Mexico Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others Summary GlobalData’s new report, "Mexico Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Managemen …
- アニリンの世界市場2015-2019About aniline Aniline is an aromatic amine. Aniline is used in a wide range of industrial applications. It is primarily used for manufacturing MDI, which is used to manufacture rigid and flexible PU foam, coatings, elastomers, sealants, and adhesives. Aniline is the most import ingredient in various rubber processing chemicals, such as 4-aminodiphenylamine. MDI, which is produced using aniline as …
- Serinus Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Serinus Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Serinus Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
